14/09/2022 – CIEM’s Choice Top 2
- Diagnosis and Management of Fingolimod-Associated Macular Edema – Frontiers in Neurology, 2022
- Multiple sclerosis and migraine: Links, management and implications – Multiple Sclerosis and Related Disorders?, 2022
CLIQUE AQUI PARA LER OS RESUMOS DOS ARTIGOS
17/08/2022 – CIEM’s Choice Top 2
- Analysis of Pregnancy-Related Attacks in Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Meta-Analysis – JAMA Network Open, 2022
- Multiple sclerosis disease-related knowledge measurement instruments show mixed performance: a systematic review – Journal of Clinical Epidemiology?, 2022
CLIQUE AQUI PARA LER OS RESUMOS DOS ARTIGOS
25/05/2022 – CIEM’s Choice Top 2
- Neuromyelitis Optica Spectrum Disorder With Anti-Aquaporin-4 Antibody: Outcome Prediction Models – Frontiers in Immunology?, 2022
- Serum MOG-IgG in children meeting multiple sclerosis diagnostic criteria – Multiple Sclerosis Journal?, 2022
CLIQUE AQUI PARA LER OS RESUMOS DOS ARTIGOS
20/04/2022 – CIEM’s Choice Top 3
- Risk of COVID-19 infection and severe disease in MS patients on different disease-modifying therapies – Multiple Sclerosis and Related Disorders?, 2022
- Longitudinal evaluation of clinical characteristics of Chinese neuromyelitis optica spectrum disorder patients with different AQP4-IgG serostatus – Multiple Sclerosis and Related Disorders?, 2022
- CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage – Journal of Neuroinflammation, 2022
CLIQUE AQUI PARA LER OS RESUMOS DOS ARTIGOS
09/03/2022 – CIEM’s Choice Top 3
- Associations of Alcohol Consumption and Smoking With Disease Risk and Neurodegeneration in Individuals With Multiple Sclerosis in the United Kingdom – JAMA ?Network Open?, 2022
- Paraneoplastic Neuromyelitis Optica Spectrum Disorder Associated With Lung Adenocarcinoma: A Case Report – Frontiers in Medicine, 2022
- Paraneoplastic Neuromyelitis Optica Spectrum Disorder Associated With Lung Adenocarcinoma: A Case Report – Brain, 2022
CLIQUE AQUI PARA LER OS RESUMOS DOS ARTIGOS
26/01/2022 – CIEM’s Choice Top 3
- Adverse events of rituximab in neuromyelitis optica spectrum disorder: a systematic review and meta-analysis – Therapeutic Advances in Neurological Disorders, 2021
- Structural and functional markers of optic nerve damage in myelin oligodendrocyte glycoprotein antibody-associated optic neuritis – Multiple Sclerosis Journal Experimental, Translational and Clinical, 2021
- The Multiple Sclerosis Data Alliance Catalogue: Enabling Web-Based Discovery of Metadata from Real-World Multiple Sclerosis Data Sources – International Journal of MS care, 2021
CLIQUE AQUI PARA LER OS RESUMOS DOS ARTIGOS
24/11/2021 – CIEM’s Choice Top 3
- The prevalence of Myocardial Infarction among Multiple Sclerosis Patients: a Systematic Review and Meta-analysis – Multiple Sclerosis and Related Disorders, 2021
- Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis – Neurology Neuroimmunology & Neuroinflammation, 2021
- Ocular adverse events from pharmacological treatment in patients with multiple sclerosis-A systematic review of the literature – Systematic Reviews, 2021
CLIQUE AQUI PARA LER OS RESUMOS DOS ARTIGOS
29/09/2021 – CIEM’s Choice Top 3
- A meta-analysis comparing first-line immunosuppressants in neuromyelitis optica – Annals of Clinical and Translational Neurology, 2021
- Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder – Journal of Neurology, Neurosurgery and Psychiatry, 2021
- Effect of Changes in MS Diagnostic Criteria Over 25 Years on Time to Treatment and Prognosis in Patients With Clinically Isolated Syndrome – Neurology, 2021
CLIQUE AQUI PARA LER OS RESUMOS DOS ARTIGOS
25/08/2021 – CIEM’s Choice Top 3
- Mortality of neuromyelitis optica spectrum disorders in a Chinese population – Annals of Clinical and Translational Neurology, 2021
- Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease Activity – Neurology Neuroimmunology & Neuroinflammation, 2021
- Systematic Assessment of Medical Diagnoses Preceding the First Diagnosis of Multiple Sclerosis – Neurology, 2021
CLIQUE AQUI PARA LER OS RESUMOS DOS ARTIGOS
23/06/2021 – CIEM’s Choice Top 3
- The prevalence of cognitive impairment in patients with neuromyelitis optica spectrum disorders (NMOSD): A systematic review and meta-analysis – Multiple Sclerosis and Related Disorders, 2021
- Neuromyelitis Optica Spectrum Disorder: Clinical Burden and Cost of Relapses and Disease-Related Care in US Clinical Practice – Neurolgy and Therapy, 2021
- Optical Coherence Tomography Angiography (OCTA) in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder – Frontiers in Neurology, 2021
CLIQUE AQUI PARA LER OS RESUMOS DOS ARTIGOS
